Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate.
The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care. Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells us...
Guardado en:
Autores principales: | Timothy Caulfield, Jim Evans, Amy McGuire, Christopher McCabe, Tania Bubela, Robert Cook-Deegan, Jennifer Fishman, Stuart Hogarth, Fiona A Miller, Vardit Ravitsky, Barbara Biesecker, Pascal Borry, Mildred K Cho, June C Carroll, Holly Etchegary, Yann Joly, Kazuto Kato, Sandra Soo-Jin Lee, Karen Rothenberg, Pamela Sankar, Michael J Szego, Pilar Ossorio, Daryl Pullman, Francois Rousseau, Wendy J Ungar, Brenda Wilson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ad7dc7b64fbc41bd87b9096edfe82feb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neural and behavioral evidence for an intrinsic cost of self-control.
por: Wouter Kool, et al.
Publicado: (2013) -
Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference
por: McCabe CF, et al.
Publicado: (2012) -
Daily steps and healthcare costs in Japanese communities
por: Shohei Okamoto, et al.
Publicado: (2021) -
THE RESEARCH OF USING «THE COST RECOVERY» METHOD IN THE COST MANAGEMENT
por: Y. Vorontsova, et al.
Publicado: (2017) -
QUALITY COST REPORTING AS A DETERMINANT OF QUALITY COSTING MATURITY
por: Andrijana Rogošić
Publicado: (2021)